* active covid-19 infection by pcr testing, pre-existing igg or igm sars-cov-2 antibodies, pregnant, known hypersensitivity to gm-csf, known active immune deficiency disease or active hiv, hbv, hcv, on active treatment with corticosteroids or other immunosupressive agent, participated in previous covid-19 vaccine study

* active covid-19 infection by pcr testing, pre-existing igg or igm sars-cov-2 antibodies, pregnant, known hypersensitivity to gm-csf, known active immune deficiency disease or active hiv, hbv, hcv, on active treatment with corticosteroids or other immunosupressive agent, participated in previous covid-19 vaccine study

- active covid-19 infection by pcr testing, pre-existing igg or igm sars-cov-2 antibodies, pregnant, known hypersensitivity to gm-csf, known active immune deficiency disease or active hiv, hbv, hcv, on active treatment with corticosteroids or other immunosupressive agent, participated in previous covid-19 vaccine study

- active covid-19 infection by pcr testing, pre-existing igg or igm sars-cov-2 antibodies, pregnant, known hypersensitivity to gm-csf, known active immune deficiency disease or active hiv, hbv, hcv, on active treatment with corticosteroids or other immunosupressive agent, participated in previous covid-19 vaccine study